Keywords: biogenerics, mart, reach, 2b, amgen, biologic, agents

US biogenerics mart to reach $2B by 2016

Article | 17 September 2007

Print This

Amgen, with biologic agents sales at over $14.0 billion, and Genentech, number two in the sector with more than $9.0 billion turnover ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in